Emerging Drugs | List of Frontiers open access articles

Community Case Study

Published on 25 Jun 2025

Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern

in Substance Use Disorders and Behavioral Addictions

Krista J. Siefried
Penny Hill
Brendan Clifford
Jared Brown
Andrew Camilleri
Sione Crawford
Paul Dessauer
Ella Dilkes-Frayne
Jack Freestone
John Gobeil

Frontiers in Public Health

doi 10.3389/fpubh.2025.1521911

3,320 views
3 citations

Review

Published on 28 Jul 2021

An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies

in Obstetrics and Gynecological Surgery

Lei Liu
Min Wang
Xianping Li
Sheng Yin
Bingqi Wang

Frontiers in Medicine

doi 10.3389/fmed.2021.682366

13,565 views
45 citations

Review

Published on 18 Jun 2025

Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?

in Obesity

Nele Steenackers
Julia Toumassian
Ellen Deleus
Ann Mertens
Matthias Lannoo
Sofia Pazmino
Amar Daniël Emanuel van Laar
Bart Van der Schueren
Roman Vangoitsenhoven

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1569468

7,318 views
1 citation

Mini Review

Published on 21 Feb 2024

Established and emerging GABAA receptor pharmacotherapy for epilepsy

in Neuropharmacology

Robert J. Richardson
Steven Petrou
Alexander Bryson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341472

12,259 views
32 citations

Review

Published on 05 Feb 2026

Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Guo-qiang Song
Bangsheng Chen
Tian-li He
Guo-qiang Hu

Frontiers in Immunology

doi 10.3389/fimmu.2026.1772031

1,039 views

Perspective

Published on 01 Aug 2022

Improving treatment for acute ischemic stroke—Clot busting innovation in the pipeline

in Pharmaceutical Innovation

Joanna Shu Ting Liu
Yiran Ding
Simone Schoenwaelder
Xuyu Liu

Frontiers in Medical Technology

doi 10.3389/fmedt.2022.946367

7,303 views
9 citations

Review

Published on 06 Dec 2022

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives

in Immunological Tolerance and Regulation

Grzegorz Kardas
Michał Panek
Piotr Kuna
Piotr Damiański
Maciej Kupczyk

Frontiers in Immunology

doi 10.3389/fimmu.2022.983852

26,221 views
56 citations

Original Research

Published on 01 Aug 2022

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma

in Cancer Immunity and Immunotherapy

Wenhao Xu
Aihetaimujiang Anwaier
Wangrui Liu
Gaomeng Wei
Jiaqi Su
Xi Tian
Jing Xia
Yuanyuan Qu
Jianyuan Zhao
Hailiang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.953721

8,943 views
20 citations

Case Report

Published on 06 Dec 2024

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use

in Addictive Disorders

Jonathan Brett
Elizabeth Knock
Kathy Watson
Steven Albert
Krista J. Siefried
Jeffrey Guss

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1490907

6,209 views
5 citations

Articles

Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern

An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies

Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?

Established and emerging GABAA receptor pharmacotherapy for epilepsy

Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD

Improving treatment for acute ischemic stroke—Clot busting innovation in the pipeline

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use